Contribution of hepatic FMO-1 in the metabolism of compound 1. Implication of clearance mechanism and extrapolation of metabolism data from preclinical species to humans

2019 ◽  
Vol 34 (1) ◽  
pp. S30
Author(s):  
Steve Bowlin ◽  
Kirk Kozminski ◽  
Amin Kamel
Author(s):  
Kathy Derakhchan ◽  
Anneli Savinainen ◽  
Jennifer Newman ◽  
Serene Josiah ◽  
Galen Carey
Keyword(s):  

2004 ◽  
Vol 181 (2) ◽  
pp. 307-314 ◽  
Author(s):  
KL Jones ◽  
DM De Kretser ◽  
DJ Phillips

Activin A and follistatin are normally present in relatively low amounts in the circulation. Heparin administration elicits a rapid and robust release of these proteins, although this phenomenon is poorly defined. In the present studies, the response to heparin administration was evaluated in the plasma of adult ewes in terms of whether it was dose-dependent, could be neutralized, was responsive to multiple stimulation, and the nature of the activin A and follistatin released. Activin A and follistatin were rapidly released by heparin in a dose-dependent manner (25, 100 or 250 IU/kg), with differences in the response as adjudged by peak concentration, timing of the peak and area under the curve. The heparin response could be blocked by pretreatment with protamine; conversely protamine injection alone (2 mg/kg) elicited release of follistatin but not activin A. Repeat administration of heparin at three-hourly intervals resulted in activin and follistatin responses to each injection, but each subsequent stimulation increased and extended the responses, consistent with saturation of the heparin clearance mechanism. Size exclusion chromatography of plasma samples confirmed that the majority of activin and follistatin released by heparin was a complex, whereas follistatin released by protamine was unbound. These data are consistent with a large pool of activin A and follistatin resident on extracellular matrices, with the rapid response implicating the vascular endothelium as the prime site of release following administration of these commonly used anticoagulant therapies.


Author(s):  
James Zhu ◽  
Jiwoong Kim ◽  
Xue Xiao ◽  
Yunguan Wang ◽  
Danni Luo ◽  
...  

The outbreak of the 2019 Novel Coronavirus (2019-nCoV) has rapidly spread from Wuhan, China to multiple countries, causing staggering number of infections and deaths. A systematic profiling of the immune vulnerability landscape of 2019-nCoV is lacking, which can bring critical insights into the immune clearance mechanism, peptide vaccine development, and antiviral antibody development. In this study, we predicted the potential of all the 2019-nCoV viral proteins to induce class I and II MHC presentation and form linear antibody epitopes. We showed that the enrichment for T cell and B cell epitopes is not uniform on the viral genome, with several focused regions that generate abundant epitopes and may be more targetable. We showed that genetic variations in 2019-nCoV, though fewer for the moment, already follow the pattern of mutations in related coronaviruses, and could alter the immune vulnerability landscape of this virus, which should be considered in the development of therapies. We create an online database to broadly share our research outcome. Overall, we present an immunological resource for 2019-nCoV that could significantly promote both therapeutic development and mechanistic research.


2021 ◽  
Vol 22 (17) ◽  
pp. 9317
Author(s):  
Konstantinos Zifkos ◽  
Christophe Dubois ◽  
Katrin Schäfer

Extracellular vesicles (EVs) compose a heterogenous group of membrane-derived particles, including exosomes, microvesicles and apoptotic bodies, which are released into the extracellular environment in response to proinflammatory or proapoptotic stimuli. From earlier studies suggesting that EV shedding constitutes a cellular clearance mechanism, it has become evident that EV formation, secretion and uptake represent important mechanisms of intercellular communication and exchange of a wide variety of molecules, with relevance in both physiological and pathological situations. The putative role of EVs in hemostasis and thrombosis is supported by clinical and experimental studies unraveling how these cell-derived structures affect clot formation (and resolution). From those studies, it has become clear that the prothrombotic effects of EVs are not restricted to the exposure of tissue factor (TF) and phosphatidylserines (PS), but also involve multiplication of procoagulant surfaces, cross-linking of different cellular players at the site of injury and transfer of activation signals to other cell types. Here, we summarize the existing and novel clinical and experimental evidence on the role and function of EVs during arterial and venous thrombus formation and how they may be used as biomarkers as well as therapeutic vectors.


Author(s):  
Peter E. Krumpe ◽  
Cahit A. Evrensel ◽  
Amgad A. Hassan

Clearance of mucus by the beating action of cilia is the primary means of removing inhaled particulates and airway debris from airways in healthy people. However many pulmonary diseases are associated with impaired mucociliary clearance mechanisms. For these patients, cough is the default airway clearance mechanism. Unfortunately most pulmonary disease patients can only produce low expiratory flow rates and have difficulty coughing for this reason.


2020 ◽  
Vol 14 ◽  
Author(s):  
Pengjie Pan ◽  
Li Xu ◽  
Hongrong Zhang ◽  
Yuan Liu ◽  
Xiaocheng Lu ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document